My Profile
Matthew Goldstein
Raising intellectual capital on Wall Street
See all posts
Thu 26 Nov 2009 | 1:01 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Poniard Pharmaceuticals, Inc.
Poniard Pharmaceuticals, Inc. (PARD.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
PARD
on other exchanges
As of 25 Nov 2009
2.10
USD
Price Change
-0.10
Percent Change
-4.55%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Martell, Ronald
47
2007
President, Chief Operating Officer, Director
Craves, Frederick
63
2004
Director
Dickson, E. Rolland
75
1998
Director
Goldfischer, Carl
50
2000
Director
Stevens, David
60
2004
Director
Littauer, Robert
60
2004
Director
Basso, Robert
64
2007
Director
Simon, Nicholas
54
2006
Director
Lyons, Gary
58
2009
Director
De Jager, Robert
67
2008
Chief Medical Officer
Weaver, Gregory
52
2009
Chief Financial Officer, Senior Vice President - Finance
McMahon, Gerald
54
2007
Chairman of the Board, Chief Executive Officer
Find out more about PARD.O
Insider Trading